首页 | 本学科首页   官方微博 | 高级检索  
     

放射性心脏损伤的研究进展
引用本文:冯宗健,鄂明艳. 放射性心脏损伤的研究进展[J]. 现代肿瘤医学, 2021, 0(1): 159-162. DOI: 10.3969/j.issn.1672-4992.2021.01.036
作者姓名:冯宗健  鄂明艳
作者单位:哈尔滨医科大学附属肿瘤医院胸部放疗科,黑龙江 哈尔滨 150081
基金项目:海燕基金项目(编号:JJZD2017-07)。
摘    要:放射治疗作为胸部恶性肿瘤非常重要的局部治疗手段,能够有效地提高局控率及改善患者远期生存.但在放疗过程中,由于解剖位置的因素,心脏作为重要的危及器官不可避免的接受照射,放射相关心脏疾病已成为胸部肿瘤放疗患者非肿瘤性死亡的主要原因之一.因此,放射性心脏损伤(RIHD)在前期临床及基础研究中均已受到越来越广泛的关注,针对RI...

关 键 词:胸部放射治疗  放射性心脏损伤  血清生物标志物

Research advances of radiation-induced heart disease
FENG Zongjian,E Mingyan. Research advances of radiation-induced heart disease[J]. Journal of Modern Oncology, 2021, 0(1): 159-162. DOI: 10.3969/j.issn.1672-4992.2021.01.036
Authors:FENG Zongjian  E Mingyan
Affiliation:Department of Chest Radiotherapy,Cancer Hospital Affiliated to Harbin Medical University,Heilongjiang Harbin 150081,China.
Abstract:As a key component of local treatment for patients with chest malignant tumors,radiation therapy can effectively improve the local control rate and patients'long-term survival.However,in the process of radiotherapy,due to the anatomic factor,the heart as a vital organ at risk is irradiated inevitably.Radiation-related heart disease had become one of the main non-tumor death causes for patients who received thoracic radiotherapy.Radiation-induced heart disease(RIHD)has received more widespread attention in clinic and basic research.A great number of studies have been carried out to explore the pathogenesis and serum biomarkers,in order to interfere with RIHD as early as possible and then improve patients'quality of life and survival.This article reviewed the development of RIHD.
Keywords:thoracic radiotherapy  radiotherapy-induced heart disease  serum biomarker
本文献已被 维普 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号